Kleinstiver, Benjamin P
Prew, Michelle S
Tsai, Shengdar Q
Nguyen, Nhu T
Topkar, Ved V
Zheng, Zongli
Joung, J Keith
Article History
Received: 1 September 2015
Accepted: 14 October 2015
First Online: 2 November 2015
Competing interests
: J.K.J. is a consultant for Horizon Discovery. J.K.J. has financial interests in Editas Medicine, Hera Testing Laboratories, Poseida Therapeutics and Transposagen Biopharmaceuticals. J.K.J.’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. A patent application has been filed describing the KKH SaCas9 variant.